Drug trials funded by the pharmaceutical industry are three times more likely to give positive results, a major study has found.
Experts warned of potential bias among researchers with financial ties to drugs companies.
The researchers, whose work was published last night in the British Medical Journal, examined the results of 195 drug trials reported in 2013.
Read more of the original article from DailyMail.
